Drawing for Serial No. 79436607

USPTO serial 79436607

Serial No. 79436607

Reviewed by CopyMark Law Group

Status 645Office Action
Filing date
Status date
Registration date
—
Examiner
FARRELL, ANNE M
Law office
TMO LAW OFFICE 118

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 645: Status 645 means the USPTO mailed a final refusal maintaining at least one objection to your application. You can respond, appeal to the Trademark Trial and Appeal Board, or allow the application to abandon.

Need help with Serial No. 79436607?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JANET G RICCIUTI

JANET G RICCIUTI JANET GILBERT RICCIUTI PC2003 KALORAMA ROAD NWWASHINGTON, DC 20009United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical, veterinary and sanitary products for medical purposes, namely gene and cell therapy products for the treatment of diseases in the nature of gene and cell therapy preparations and genetically engineered pharmaceutical preparations for the treatment of diseases and disorders of genetic etiology; chemical preparations for medical and pharmaceutical use or for veterinary use, namely gene and cell therapy products for the treatment of diseases; biological preparations for medical and pharmaceutical use or for veterinary use, namely gene and cell therapy products for the treatment of diseases and disorders of genetic etiology; nutritional substances for microorganisms for medical use; kits for preparing cells or for selecting biologically active compounds comprised of gene therapies, namely biologically active virus and cell preparations for the treatment of diseases and disorders of genetic etiologyACTIVE—
009Electronic database in the field of medical patient records; Downloadable Software for artificial intelligence and machine learning software; Downloadable mobile applications for artificial intelligence and machine learning software; Downloadable Software as a Medical Device ([SaMD]) for artificial intelligence and machine learning software; Downloadable computer programs for artificial intelligence and machine learning software; Computer platforms in the form of recorded or downloadable software for artificial intelligence and machine learning softwareACTIVE—
010Surgical, medical apparatus and instruments for medical use; Testing apparatus for medical use for the diagnosis and/or follow-up the evolution of diseases namely genetic diseases; Diagnostic apparatus for medical use for the diagnosis and/or follow-up the evolution of diseases namely genetic diseases; Medical devices namely medical, biological and gene therapy and cell therapy testing kits to assist in collecting, assessing and determining optimal drugs and biological products comprising specimen transport tubes for use with blood, genetic materials, fluids, tissues, samples and other human components and related elements, frozen specimen bags, specimen collection and transport instructions, foam coolers for specimens, emergency medical service foam coolers for specimens, cardboard shipping containers for specimens, and shipping labels for specimens, all for medical use; medical devices, namely active implantable medical devices namely implantable drug delivery pumps and implantable drug delivery portsACTIVE—
035Providing industry expertise in commercial affairs in the field of health sector; Business management assistance, namely, commercial or industrial company management assistance; Collection of data in a central file in the nature of collection of information into computer databases in the field of health sector; Business advisory and assistance services in company organization and management, particularly in the context of project selection, support and acceleration program; company audits for commercial analysesACTIVE—
036Providing financing for inventions through, in particular, public or private financing; Financing appraisal through monitoring of use of public or private financing; Providing financial subsidies, namely, providing project grants for health awareness projects; financial investments in the field of medical research; providing financial investment research; fundraising services for others for the purpose of medical research; funds investment; financial consulting relating to searching for financial partnershipsACTIVE—
041Education services in the nature of digital training platforms, development of training digital content, photography and video for education purposes; information relating to entertainment and on education; education and entertainment services, namely, organization of educational competitions; publication of electronic books and journals online; organizing and conducting training workshops, colloquiums, conferences, congresses, seminars, symposiums for cultural or educational purposes in the field of health; providing online non-downloadable electronic publications in the nature of books, articles, reviews, abstracts, posters, reports, projects, dissertations, magazines, brochures in the field of health from a global computer network or the internetACTIVE—
042Services provided by engineers namely evaluations, assessments and research services in the field of gene and cell therapy preparations and genetically engineered pharmaceutical products for the treatment of diseases and disorders of genetic etiology; Services provided by engineers namely appraisals and assessments in the field of medical research specifically gene and cell therapy preparations and genetically engineered pharmaceutical products for the treatment of diseases and disorders of genetic etiology; research and development of new products for others; technical research services, namely, technical project studies in the health sector; scientific research for medical purposes in the field of the treatment of diseases in the nature of gene and cell therapy and of diseases and disorders of genetic etiology; scientific research in the nature of conducting clinical trials for others; computer platform as a service (PAAS) featuring computer software platforms for imaging and physiology; research and development of new pharmaceutical, veterinary and sanitary products for third parties; fundamental and applied research in the scientific, technological or industrial field; Services in functional genomics namely providing educational training, workshops, conferences for identifying, characterizing, validating or developing biologically active molecules; technical research services, namely, technical project study in the health sector; professional scientific research, consultancy, unrelated to business operations, in the field of scientific research and gene and cell therapiesACTIVE—
044Health services in the nature of medical consultation, medical examination, medical testing for the diagnosis and treatment of persons, genetic testing; consultation with respect to pharmacy; provision of medical information in the pharmaceutical field; clinical medical consultation servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 11, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jul 11, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 11, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 27, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 27, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 27, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 5, 2026RFNTREFUSAL PROCESSED BY IB—
Jan 21, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 21, 2026RFRRREFUSAL PROCESSED BY MPU—
Dec 18, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 17, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 15, 2025DOCKASSIGNED TO EXAMINER—
Nov 9, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 9, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 7, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance